Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...

Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

The Health and Human Services Department says the county’s Treatment Court program is ending due to an unfilled key staff ...

Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...

UNAIDS warns that cuts to HIV/AIDS funding by rich donors, including the U.S., have led some poorer nations to boost their ...

Despite an apparent reversal on mass layoffs, the Department of Veterans Affairs is quietly advancing a workforce reduction, ...

Healthcare delivery organizations are saying they have yet to fully recover financially from the COVID-19 pandemic, and a high level of uncertainty around changing regulations and economic conditions ...

Trump celebrated when the Supreme Court limited nationwide blocks on his policies, but judges are finding other ways to hinder his priorities.

An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...

Hospitals, health systems and physician practices are shifting their operational and financial strategies in the face of ...

The idea of making the U.S. more like Europe is anathema to many in the Trump administration. But that’s what the Make ...

There were 498 opioid overdose deaths in the third quarter last year, the lowest number of deaths in a single quarter since ...